Silicosis

Silicosis is a chronic pulmonary disease caused by the inhalation of silica-containing aerosols, which contain free silicon dioxide. The main mechanism of its pathogenesis is an inflammatory reaction with the formation of fibrous nodules in the lungs. With prolonged exposure to quartz dust, a gradual loss of the functional capacity of the lung tissue occurs, which leads to severe clinical manifestations such as shortness of breath, cough, decreased physical activity and, ultimately, to the development of respiratory failure. Silicosis is considered one of the most studied occupational diseases, especially among workers in mining, construction and other industries associated with high levels of dust formation.

History of the disease and interesting historical facts

Silicosis has been with humanity for centuries, but its medical characteristics were more clearly defined in the late 19th century. The first documented case of the disease was described in 1700, when London physician John Hesketh mentioned lung diseases among windmill workers. At the beginning of the 20th century, attention to silicosis increased due to mass industrialization and the need to protect workers in mines. Since the 1930s, methods for preventing and treating this disease have been actively developed. Interestingly, at that time silicosis was called "miner's disease", and even in popular scientific works it was described as the scourge of the coal industry, which emphasized its widespread prevalence among workers in difficult conditions.

Epidemiology

According to the World Health Organization (WHO), silicosis is a significant cause of morbidity and mortality worldwide. According to data published in 2021, the incidence of silicosis ranged from 11.3% to 4.1% among miners in different regions of the world. In some countries where mining and construction industries are prevalent, the incidence rate can reach 15.1% and higher. It is important to note that in recent decades, the incidence has tended to decrease in countries with high living standards and strict occupational safety standards, but the incidence remains high in developing countries due to the lack of adequate worker protection.

Genetic predisposition to this disease

Research suggests that although silicosis is primarily a result of environmental factors, there is a genetic predisposition that may influence susceptibility to the disease. Scientists have identified a number of genes, such as **MMP1**, **MMP9**, and **IL6**, that may be involved in the process of pulmonary fibrosis. Certain mutations in these genes may increase the risk of developing pulmonary fibrosis when exposed to silica. Microsatellite polymorphisms are also suspected of affecting the body’s immune response and its ability to repair lung tissue after injury.

Risk factors for the development of this disease

The list of risk factors for the development of silicosis includes both physical and chemical factors, among which are:

• Long-term exposure to silica dust, especially from work in mining, quarrying, construction and manufacturing industries.
• Low ventilation and lack of personal protective equipment in the workplace.
• Smoking, which significantly worsens the harmful effects of dust on the lungs.
• Predisposition to allergic diseases and other pulmonary pathologies.

In addition, poor nutrition, lack of physical activity, and pre-existing lung diseases such as chronic bronchitis and asthma may be contributing factors.

Diagnosis of this disease

Silicosis is diagnosed based on clinical symptoms, anamnesis data, and the results of laboratory and instrumental studies.

The main symptoms include:

• Chronic cough.
• Shortness of breath that progresses over time.
• Chest pain.
• Fatigue during physical activity.

Laboratory tests may include:

• A general blood test to identify possible inflammatory processes.
• Analysis for the presence of antibodies to silica.

Radiological examinations describe characteristic changes in the lungs, such as the appearance of nodular consolidations. CT scans of the chest demonstrate the presence of characteristic fibrotic changes.

Other diagnostic methods are:

• Spirometry to assess lung function.
• Bronchoscopy with biopsy to clarify the diagnosis.

Differential diagnosis includes exclusion of other causes of pulmonary fibrosis, such as asbestosis and toxic pneumonitis.

Treatment

There is currently no specific treatment for silicosis, but there is a role for supportive care aimed at improving the quality of life of patients.

General treatment may include:

• Avoid further contact with silicon oxides.
• Maintaining a physical activity and diet regimen.

Pharmacological treatment may include:

• Anti-inflammatory drugs (glucocorticosteroids).
• Bronchodilators to improve airway patency.

Surgical treatment may be necessary if complications such as lung infections or pleurisy develop.

Other treatments may include pulmonary rehabilitation, physical therapy, and the use of oxygen therapy in cases of progressive respiratory failure.

List of medications used to treat this disease

• Hydrocortisone.
• Prednisolone.
• Thiophylline.
• Salbutamol.

Disease monitoring

Monitoring a patient with silicosis includes regular medical examinations and laboratory tests to assess lung function and overall health.

The control stages may look like this:

• Regular consultation with a pulmonologist.
• Volumetric spirometric study once every 6-12 months.
• Control of radiography or CT scan of the lungs.

The prognosis for silicosis depends on the severity of the disease, the presence of comorbidities, and adherence to lifestyle recommendations. Possible complications include the development of chronic obstructive pulmonary disease and pulmonary hypertension.

Age-related features of the disease

Silicosis is more common in adults working in hazardous conditions, but its manifestations may vary depending on the patient's age. In young people, the disease may develop more rapidly and acutely, while in older patients it may manifest itself as fibrosis of the lung tissue with less pronounced symptoms, viability and adaptation of the body. The disease is extremely rare in children and adolescents.

Questions and Answers

• What is silicosis? Silicosis is a chronic lung disease caused by long-term exposure to silica dust, leading to the formation of fibrotic changes in the lungs.
• How is silicosis diagnosed? Diagnosis of silicosis is based on radiographic data, clinical symptoms and spirometry results.
• What are the risk factors for silicosis? The main risk factors are long-term exposure to silica dust, smoking and poor occupational safety.
• What is the treatment for silicosis? There is no specific treatment, but anti-inflammatory drugs and supportive therapy may be used.
• What is the prognosis for silicosis? The prognosis depends on the stage of the disease and the level of medical control, while the absence of a third way worsens the health condition.